Publications by authors named "Jim Thom"

Claim this Profile
S
Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke.
Mohammad Al-Tamimi, Elizabeth E Gardiner, Jim Y Thom, Yang Shen, Matthew N Cooper

Stroke· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease.
Emmanuel J Favaloro, Jim Thom, David Patterson, Sarah Just, Maria Baccala

Blood Coagul Fibrinolysis· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticles.
Laura Pearson, Jim Thom, Murray Adams, Robert Oostryck, Rom Krueger

Int J Lab Hematol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
Emmanuel J Favaloro, Jim Thom, David Patterson, Sarah Just, Tracy Dixon

Thromb Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial.
Gerald Yong, Jamie Rankin, Louise Ferguson, Jim Thom, John French

Am Heart J· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk.
John W Eikelboom, Graeme J Hankey, Jim Thom, Deepak L Bhatt, P Gabriel Steg

Circulation· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-reactive protein in ischemic stroke and its etiologic subtypes.
John W Eikelboom, Graeme J Hankey, Ross I Baker, Andrew McQuillan, Jim Thom

J Stroke Cerebrovasc Dis· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
Lisa F Lincz, Murray J Adams, Fiona E Scorgie, Jim Thom, Ross I Baker

Blood Coagul Fibrinolysis· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging technologies in hemostasis diagnostics: a report from the Australasian Society of Thrombosis and Haemostasis Emerging Technologies Group.
Murray Adams, Chris Ward, Jim Thom, Alessandra Bianchi, Emma Perrin

Semin Thromb Hemost· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tissue factor pathway in ischemic stroke.
Murray J Adams, Jim Thom, Graeme J Hankey, Ross Baker, Grace Gilmore

Blood Coagul Fibrinolysis· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation.
Sim Yee Lean, Paul Ellery, Leesa Ivey, Jim Thom, Robert Oostryck

Haematologica· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error rates.
Emmanuel J Favaloro, Roslyn Bonar, Geoff Kershaw, John Sioufi, Jim Thom

Lab Hematol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation.
Murray Adams, Liza Breckler, Paul Stevens, Jim Thom, Ross Baker

Haematologica· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.
Jim Thom, Leesa Ivey, Grace Gilmore, John W Eikelboom

Blood Coagul Fibrinolysis· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein Z in ischemic stroke and its etiologic subtypes.
Andrew M McQuillan, John W Eikelboom, Graeme J Hankey, Ross Baker, Jim Thom

Stroke· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes.
Paul Cherian, Graeme J Hankey, John W Eikelboom, Jim Thom, Ross I Baker

Stroke· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates.
Emmanuel J Favaloro, Melinda Bukuya, Teresa Martinelli, Joanne Tzouroutis, Elizabeth Duncan, Jim Thom

Thromb Haemost· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis